Wordt geladen...
The evolution of recombinant thrombolytics: Current status and future directions
Cardiovascular disorders are on the rise worldwide due to alcohol abuse, obesity, hypertension, raised blood lipids, diabetes and age-related risks. The use of classical antiplatelet and anticoagulant therapies combined with surgical intervention helped to clear blood clots during the inceptive year...
Bewaard in:
| Gepubliceerd in: | Bioengineered |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5553328/ https://ncbi.nlm.nih.gov/pubmed/27696935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21655979.2016.1229718 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|